Short Interest in Bionano Genomics, Inc. (NASDAQ:BNGO) Grows By 11.4%

Bionano Genomics, Inc. (NASDAQ:BNGO) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 17,650,000 shares, a growth of 11.4% from the December 31st total of 15,840,000 shares. Approximately 12.7% of the shares of the stock are sold short. Based on an average daily volume of 6,670,000 shares, the short-interest ratio is presently 2.6 days.

Institutional Trading of Bionano Genomics

Large investors have recently modified their holdings of the company. Carret Asset Management LLC raised its stake in Bionano Genomics by 89.0% during the 3rd quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock valued at $39,000 after purchasing an additional 40,055 shares during the period. GSA Capital Partners LLP bought a new stake in shares of Bionano Genomics in the 3rd quarter valued at approximately $46,000. Finally, Geode Capital Management LLC increased its holdings in Bionano Genomics by 47.3% in the third quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock worth $401,000 after buying an additional 283,639 shares during the last quarter. Institutional investors and hedge funds own 11.35% of the company’s stock.

Bionano Genomics Stock Up 2.1 %

Shares of NASDAQ:BNGO traded up $0.11 during trading on Monday, hitting $5.30. The company’s stock had a trading volume of 233,420 shares, compared to its average volume of 352,757. The company has a market capitalization of $10.35 million, a PE ratio of -0.04 and a beta of 2.22. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.99 and a current ratio of 1.43. The stock’s 50-day moving average price is $12.61 and its two-hundred day moving average price is $20.61. Bionano Genomics has a fifty-two week low of $4.75 and a fifty-two week high of $81.00.

Analyst Upgrades and Downgrades

Separately, LADENBURG THALM/SH SH cut shares of Bionano Genomics from a “buy” rating to a “neutral” rating in a research note on Friday, November 15th.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.